Sunday, April 19, 2009

Pfizer to Begin Embryonic Stem Cell Trials

This week Pfizer is set to announce its financial backing of the development of an embryonic stem cell therapy to cure age-related macular degeneration (AMD). The clinical trial would begin in about two years.
Read about it here.

No comments: